These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12505526)

  • 1. Human NK cells and their receptors.
    Moretta L; Biassoni R; Bottino C; Cantoni C; Pende D; Mingari MC; Moretta A
    Microbes Infect; 2002 Dec; 4(15):1539-44. PubMed ID: 12505526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.
    Moretta A; Bottino C; Vitale M; Pende D; Cantoni C; Mingari MC; Biassoni R; Moretta L
    Annu Rev Immunol; 2001; 19():197-223. PubMed ID: 11244035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
    Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
    J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.
    Banerjee P; Feuer G; Barker E
    J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory and activating receptors involved in immune surveillance by human NK and myeloid cells.
    Colonna M; Nakajima H; Cella M
    J Leukoc Biol; 1999 Nov; 66(5):718-22. PubMed ID: 10577499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer (NK)-cell function and antileukemic activity of a large population of CD3+/CD8+ T cells expressing NK receptors for major histocompatibility complex class I after "three-loci" HLA-incompatible bone marrow transplantation.
    Albi N; Ruggeri L; Aversa F; Merigiola C; Tosti A; Tognellini R; Grossi CE; Martelli MF; Velardi A
    Blood; 1996 May; 87(9):3993-4000. PubMed ID: 8611732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human NK cells: From surface receptors to clinical applications.
    Moretta L; Pietra G; Vacca P; Pende D; Moretta F; Bertaina A; Mingari MC; Locatelli F; Moretta A
    Immunol Lett; 2016 Oct; 178():15-9. PubMed ID: 27185471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production.
    Mingari MC; Vitale C; Cambiaggi A; Schiavetti F; Melioli G; Ferrini S; Poggi A
    Int Immunol; 1995 Apr; 7(4):697-703. PubMed ID: 7547697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2B4 (CD244)-CD48 interactions provide a novel MHC class I-independent system for NK-cell self-tolerance in mice.
    McNerney ME; Guzior D; Kumar V
    Blood; 2005 Aug; 106(4):1337-40. PubMed ID: 15870174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface molecules involved in the activation and regulation of T or natural killer lymphocytes in humans.
    Moretta A; Ciccone E; Pantaleo G; Tambussi G; Bottino C; Melioli G; Mingari MC; Moretta L
    Immunol Rev; 1989 Oct; 111():145-75. PubMed ID: 2697680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta-mediated recognition.
    Pietra G; Romagnani C; Falco M; Vitale M; Castriconi R; Pende D; Millo E; Anfossi S; Biassoni R; Moretta L; Mingari MC
    Eur J Immunol; 2001 Dec; 31(12):3687-93. PubMed ID: 11745389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NK cell activation: distinct stimulatory pathways counterbalancing inhibitory signals.
    Bakker AB; Wu J; Phillips JH; Lanier LL
    Hum Immunol; 2000 Jan; 61(1):18-27. PubMed ID: 10658974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
    Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
    Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies.
    Sivori S; Vitale M; Bottino C; Marcenaro E; Sanseverino L; Parolini S; Moretta L; Moretta A
    Eur J Immunol; 1996 Oct; 26(10):2487-92. PubMed ID: 8898964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection.
    Held W; Cado D; Raulet DH
    J Exp Med; 1996 Nov; 184(5):2037-41. PubMed ID: 8920892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the natural killer cell receptor repertoire.
    Raulet DH; Vance RE; McMahon CW
    Annu Rev Immunol; 2001; 19():291-330. PubMed ID: 11244039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mechanism of antitumor response involving the expansion of CD3+/CD56+ large granular lymphocytes triggered by a tumor-expressed activating ligand.
    Costello RT; Sivori S; Mallet F; Sainty D; Arnoulet C; Reviron D; Gastaut JA; Moretta A; Olive D
    Leukemia; 2002 May; 16(5):855-60. PubMed ID: 11986947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1.
    Pérez-Villar JJ; Melero I; Navarro F; Carretero M; Bellón T; Llano M; Colonna M; Geraghty DE; López-Botet M
    J Immunol; 1997 Jun; 158(12):5736-43. PubMed ID: 9190923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human NK cells: from HLA class I-specific killer Ig-like receptors to the therapy of acute leukemias.
    Moretta A; Locatelli F; Moretta L
    Immunol Rev; 2008 Aug; 224():58-69. PubMed ID: 18759920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.
    Pende D; Sivori S; Accame L; Pareti L; Falco M; Geraghty D; Le Bouteiller P; Moretta L; Moretta A
    Eur J Immunol; 1997 Aug; 27(8):1875-80. PubMed ID: 9295021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.